Managing type 1 diabetes in frailty.
| Autor: | Zac-Varghese S; Diabetes and Endocrinology, East and North Hertfordshire NHS Trust, Stevenage, UK sagen.zac-varghese@nhs.net., Summerhayes B; Diabetes and Endocrinology, East and North Hertfordshire NHS Trust, Stevenage, UK., Winocour P; Diabetes and Endocrinology, East and North Hertfordshire NHS Trust, Welwyn, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | BMJ case reports [BMJ Case Rep] 2022 Dec 26; Vol. 15 (12). Date of Electronic Publication: 2022 Dec 26. |
| DOI: | 10.1136/bcr-2022-253779 |
| Abstrakt: | Managing type 1 diabetes in frail elderly people can be logistically challenging, particularly for those living alone. District nurse visits are unpredictable and coincide poorly with meal time insulin regimes. Elderly people, particularly those with dementia, have variable oral intake and activity. For some, poor glycaemic control leads to frequent and prolonged inpatient admissions. The use of technology, such as flash glucose monitoring, and the use of analogue insulins can be helpful in this setting. Increased monitoring enables more accurate titration of insulin doses and the information can be accessed by healthcare professionals and carers remotely. Longer lasting analogue insulins allow for a greater margin of error in the timing of insulin administration. Competing Interests: Competing interests: SZ-V is an Affiliated Assistant Professor, University of Cambridge; Honorary Lecturer, Imperial College London and Visiting Lecturer, University of Hertfordshire. PW has received honoraria for delivering educational meetings and/or attending advisory boards for AstraZeneca, Eli Lilly, Novo Nordisk, Sanofi, MSD, Janssen and Vifor Pharmaceuticals. (© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|